-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Applied Genetic Technologies Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from 2012 to 2022.
- Applied Genetic Technologies Corp Nonoperating Income (Expense) for the quarter ending September 30, 2022 was -$991K, a 49.5% decline year-over-year.
- Applied Genetic Technologies Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was -$2.9M, a 62.6% decline year-over-year.
- Applied Genetic Technologies Corp annual Nonoperating Income (Expense) for 2022 was -$2.58M, a 85.3% decline from 2021.
- Applied Genetic Technologies Corp annual Nonoperating Income (Expense) for 2021 was -$1.39M, a 218% decline from 2020.
- Applied Genetic Technologies Corp annual Nonoperating Income (Expense) for 2020 was $1.18M, a 51.9% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)